DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nisoldipine
Nisoldipine
Optum Essential Health Benefits Enhanced Formulary PDL January
Supplementary Materials
Label (PDF)
Grapefruit Juice May Cause Prescription Drug Interactions
Report
Label (PDF)
Download Product Insert (PDF)
2021 Formulary List of Covered Prescription Drugs
Therapeutic Class Overview Anticonvulsants
Calcium Channel Blockers
Clinically Relevant Drug Interactions with Antiepileptic Drugs
Nisoldipine (Sular)
Development of Fast Dissolving Tablets of Nisoldipine by Solid Dispersion Technology Using Poloxamer 407 and Poloxamer 188
Treatment in Hypertension Inadequately Controlled by Atenolol B.I
Principal Component Analysis of HPLC Retention Data and Molecular Modeling Structural Parameters of Cardiovascular System Drugs
Drug Repurposing for Mitochondrial Diseases Using a Pharmacological Model of Complex I Deficiency in the Yeast Yarrowia Lipolytica
Pharmacogenomic Associations Tables
Fosphenytoin Sodium Injection, USP Rx Only WARNING
Top View
MSM PDL Document 010109
Medication Guide for a Safe Recovery
PDL)/Non-Preferred Drug List (NPDL
Effects of Verapamil and Nisoldipine on Human Platelets: in Vivo and in Vitro Studies
Montana Medicaid Preferred Drug List (PDL) Revised July 14, 2021
Supplemental Data for Drug Metabolism and Disposition
Differential Effects of Calcium Antagonists on ABCG2/BCRP-Mediated Drug Resistance and Transport in SN-38-Resistant Hela Cells
Calcium Channel Blockers Therapeutic Class Review (TCR) December 1, 2013
SULAR (Nisoldipine)
POCKET GUIDE of DRUG INTERACTIONS Second Edition
Long-Term Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Patients with Diabetic Nephropathy Response to Tarnow Et Al
FEP 5 Tier Rx Drug Formulary (607) Standard Option
Calcium Channel Blockers Review 10/06/2008
DILANTIN (Phenytoin Sodium) Injection
Drug-Drug Interactions Avoid Serious Adverse PREVENTING DRUG-DRUG INTERACTIONS PART 1 of a SERIES Current P SYCHIATRY
DBL™ Phenytoin Injection BP Solution for Injection
Medical Necessity Criteria for Drug Class: Calcium Channel Blockers
Drugs Covered in 90-Day Supplies During COVID-19 Emergency May 20, 2020
A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
Rx90 Drug List Template
Comparative Study of Calcium-Channel Blockers on Cell
Pharmacological Effects of Grapefruit Juice
Drug-Induced Hyperpigmentation: Review and Case Series
Advances in Current Medication and New Therapeutic Approaches in Epilepsy
Food/Drug Interactions
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Ambetter 90-Day-Maintenance Drug List- 2020
Drug Class Review on Calcium Channel Blockers
Medications and Grapefruit
Therapeutic Class Overview Anticonvulsants
Patient Handbook Adult IOP
Paragraph IV Patent Certifications (PPIV)
Interactions with PBC Agents
(FEHB) Program Prescription Drug Formulary, Effective August 1, 2018
Bioavailability Enhancement of Poorly Water-Soluble Drugs Via Nanocomposites: Formulation–Processing Aspects and Challenges
3-Tier Preferred Drug List
Denton Thesis Final
Enhanced Oral Bioavailability of Nisoldipine- Piperine-Loaded Poly
Repurposing Drugs to Fast-Track Therapeutic Agents for the Treatment of Cryptococcosis
Medications Associated with Geriatric Syndrome (MAGS) and Their Prevalence in Older Hospitalized Adults Discharged to Skilled Nursing Facilities